TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Why I’m Avoiding Valeant Pharmaceutical Intl Inc. Like the Plague

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could be many years away from seeing its stock rally.

    Read more »

    Investing

    Will Valeant Pharmaceuticals Intl Inc. Survive the Trump Presidency?

    With President Trump openly critical of price-hiking pharmaceutical companies, can Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) survive the next four years?

    Read more »

    The Motley Fool
    Investing

    How 2017 Will Unfold for Valeant Pharmaceuticals Intl Inc.

    A mountain of debt, difficult no-win decisions, and a potential battle with the Trump administration are just some of the…

    Read more »

    The Motley Fool
    Investing

    Explaining the Interest Costs of Valeant Pharmaceuticals Intl Inc.

    With crippling interest costs, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will implode by the end of 2017.

    Read more »

    The Motley Fool
    Investing

    Simple Math Doesn’t Work at Valeant Pharmaceuticals Intl Inc.

    Although Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) announced major news in the past week, this will not change the end result:…

    Read more »

    The Motley Fool
    Tech Stocks

    Valeant Pharmaceuticals Intl Inc. on Fire to Start the Year

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has made some huge sales in the new year, helping the company to offload some…

    Read more »

    The Motley Fool
    Investing

    On the Move! Valeant Pharmaceuticals Intl Inc. Rises Again

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) announced the sale of some non-core assets this week which will help pay down the…

    Read more »

    Investing

    Valeant Pharmaceuticals Intl Inc. Just Sold Over US$2 Billion in Assets: What Now?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is finally selling assets, but the proceeds don't cover enough of the mountain of debt…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical Intl Inc. Just Raised its Drug Prices Again

    Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) is doing everything it can to raise money to pay back its debt. It's selling…

    Read more »

    The Motley Fool
    Investing

    3 CEOs Who Actually Earn Their Pay

    The former CEO of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), Michael Pearson, was the highest-paid CEO in Canada at $182.9 million.…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A Stock at the Top of My List!

    Going into 2017, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are at the top of my watch list.

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Will Fail to Re-Invent Itself

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) had a horrible year, and I believe the stock is far from rallying.

    Read more »